5,435 research outputs found

    3-D SPH simulations of colliding winds in eta Carinae

    Full text link
    We study colliding winds in the superluminous binary eta Carinae by performing three-dimensional, Smoothed Particle Hydrodynamics (SPH) simulations. For simplicity, we assume both winds to be isothermal. We also assume that wind particles coast without any net external forces. We find that the lower density, faster wind from the secondary carves out a spiral cavity in the higher density, slower wind from the primary. Because of the phase-dependent orbital motion, the cavity is very thin on the periastron side, whereas it occupies a large volume on the apastron side. The model X-ray light curve using the simulated density structure fits very well with the observed light curve for a viewing angle of i=54 degrees and phi=36 degrees, where i is the inclination angle and phi is the azimuth from apastron.Comment: 6 pages, 3 figures, To be published in Proceedings of IAU Symposium 250: Massive Stars as Cosmic Engines, held in Kauai, Hawaii, USA, Dec 2007, edited by F. Bresolin, P.A. Crowther & J. Puls (Cambridge University Press

    X-ray Modeling of \eta\ Carinae and WR140 from SPH Simulations

    Full text link
    The colliding wind binary (CWB) systems \eta\ Carinae and WR140 provide unique laboratories for X-ray astrophysics. Their wind-wind collisions produce hard X-rays that have been monitored extensively by several X-ray telescopes, including RXTE. To interpret these RXTE X-ray light curves, we model the wind-wind collision using 3D smoothed particle hydrodynamics (SPH) simulations. Adiabatic simulations that account for the absorption of X-rays from an assumed point source at the apex of the wind-collision shock cone by the distorted winds can closely match the observed 2-10keV RXTE light curves of both \eta\ Car and WR140. This point-source model can also explain the early recovery of \eta\ Car's X-ray light curve from the 2009.0 minimum by a factor of 2-4 reduction in the mass loss rate of \eta\ Car. Our more recent models relax the point-source approximation and account for the spatially extended emission along the wind-wind interaction shock front. For WR140, the computed X-ray light curve again matches the RXTE observations quite well. But for \eta\ Car, a hot, post-periastron bubble leads to an emission level that does not match the extended X-ray minimum observed by RXTE. Initial results from incorporating radiative cooling and radiatively-driven wind acceleration via a new anti-gravity approach into the SPH code are also discussed.Comment: 5 pages, 3 figures, Proceedings of the 39th Li\'ege Astrophysical Colloquium, held in Li\`ege 12-16 July 2010, edited by G. Rauw, M. De Becker, Y. Naz\'e, J.-M. Vreux, P. William

    Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs

    Get PDF
    Background: n-3 fatty acids are increasingly being administered to cancer patients for the treatment of cachexia, and it is thus important to know of any potential interactions with ongoing cytotoxic drug therapy. Materials and methods: For this reason eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were administered to mice bearing the cachexia-inducing MAC16 colon adenocarcinoma, and the effect of epothilone, gemcitabine, 5-fluorouracil and cyclophosphamide on tumour growth and body weight determined. Results: Epothilone alone had a minimal effect on tumour growth rate, but this was potentiated by DHA, while for 5-fluorouracil and cyclophosphamide tumour growth inhibition was enhanced by EPA. The antitumour effect of gemcitabine was not altered by either fatty acid. EPA arrested the development of cachexia, while DHA had no effect and the same was true for their effect on tumour growth rate. The anticachectic effect of EPA was only seen in combination with 5-fluorouracil. Conclusion: These results suggest that n-3 fatty acids do not interfere with the action of chemotherapy and may potentiate the effect of certain agents

    Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.

    Get PDF
    BackgroundDespite inhaled medications that decrease exacerbation risk, some COPD patients experience frequent exacerbations. We determined prospective risk factors for exacerbations among subjects in the COPDGene Study taking inhaled medications.Methods2113 COPD subjects were categorized into four medication use patterns: triple therapy with tiotropium (TIO) plus long-acting beta-agonist/inhaled-corticosteroid (ICS ± LABA), tiotropium alone, ICS ± LABA, and short-acting bronchodilators. Self-reported exacerbations were recorded in telephone and web-based longitudinal follow-up surveys. Associations with exacerbations were determined within each medication group using four separate logistic regression models. A head-to-head analysis compared exacerbation risk among subjects using tiotropium vs. ICS ± LABA.ResultsIn separate logistic regression models, the presence of gastroesophageal reflux, female gender, and higher scores on the St. George's Respiratory Questionnaire were significant predictors of exacerbator status within multiple medication groups (reflux: OR 1.62-2.75; female gender: OR 1.53 - OR 1.90; SGRQ: OR 1.02-1.03). Subjects taking either ICS ± LABA or tiotropium had similar baseline characteristics, allowing comparison between these two groups. In the head-to-head comparison, tiotropium users showed a trend towards lower rates of exacerbations (OR = 0.69 [95 % CI 0.45, 1.06], p = 0.09) compared with ICS ± LABA users, especially in subjects without comorbid asthma (OR = 0.56 [95% CI 0.31, 1.00], p = 0.05).ConclusionsEach common COPD medication usage group showed unique risk factor patterns associated with increased risk of exacerbations, which may help clinicians identify subjects at risk. Compared to similar subjects using ICS ± LABA, those taking tiotropium showed a trend towards reduced exacerbation risk, especially in subjects without asthma.Trial registrationClinicalTrials.gov NCT00608764, first received 1/28/2008

    Constraints on decreases in Eta Carinae's mass loss from 3D hydrodynamic simulations of its binary colliding winds

    Get PDF
    Recent work suggests that the mass-loss rate of the primary star (Eta A) in the massive colliding wind binary Eta Carinae dropped by a factor of 2-3 between 1999 and 2010. We present results from large- (r=1545au) and small- (r=155au) domain, 3D smoothed particle hydrodynamic (SPH) simulations of Eta Car's colliding winds for 3 Eta A mass-loss rates (2.4, 4.8, and 8.5 x 10^-4 M_sun/yr), investigating the effects on the dynamics of the binary wind-wind collision (WWC). These simulations include orbital motion, optically thin radiative cooling, and radiative forces. We find that Eta A's mass-loss rate greatly affects the time-dependent hydrodynamics at all spatial scales investigated. The simulations also show that the post-shock wind of the companion star (Eta B) switches from the adiabatic to the radiative-cooling regime during periastron passage. The SPH simulations together with 1D radiative transfer models of Eta A's spectra reveal that a factor of 2 or more drop in Eta A's mass-loss rate should lead to substantial changes in numerous multiwavelength observables. Recent observations are not fully consistent with the model predictions, indicating that any drop in Eta A's mass-loss rate was likely by a factor < 2 and occurred after 2004. We speculate that most of the recent observed changes in Eta Car are due to a small increase in the WWC opening angle that produces significant effects because our line-of-sight to the system lies close to the dense walls of the WWC zone. A modest decrease in Eta A's mass-loss rate may be responsible, but changes in the wind/stellar parameters of Eta B cannot yet be fully ruled out. We suggest observations during Eta Car's next periastron in 2014 to further test for decreases in Eta A's mass-loss rate. If Eta A's mass-loss rate is declining and continues to do so, the 2014 X-ray minimum should be even shorter than that of 2009.Comment: 38 pages, 25 figures, 1 table. Accepted for publication in MNRA
    corecore